© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Prilocaine hydrochloride didn’t just pop up out of thin air. This local anesthetic, which many folks know from the dentist’s chair or the operating room, has roots tracing back to the mid-20th century. Swedish chemists were working hard in the search for alternatives to lidocaine, and their efforts paid off. They combined scientific curiosity with a growing need for safer, less-toxic numbing agents. This was a time when medicine started to pay more attention to patient comfort and the risks tied to common drugs. That push for innovation helped bring prilocaine hydrochloride to the world. Over the decades, its development reflects a bigger story about valuing both efficacy and safety in medicine.
Prilocaine hydrochloride is known as a fast-acting local anesthetic, mostly used for numbing skin or mucous membranes during small surgeries, dental work, or other minor procedures. It shows up as a white to off-white crystalline powder, with no particular smell but a slightly bitter taste if you’re unlucky enough to get it in your mouth. Common on pharmacy shelves, prilocaine sets itself apart from other anesthetics by having a lower risk of causing allergic reactions or cardiac side effects. Doctors often prefer it where patients have special health concerns or a history of sensitivity to other numbing agents. Its good safety margin matters not only to patients but also to caregivers who need predictable outcomes.
Looking closely at prilocaine hydrochloride, its physical form helps in both handling and application. The powder dissolves well in water, supporting its use in injection and topical creams. Its melting point falls between 166°C and 168°C, which suggests stability in typical drug manufacturing and storage. The chemical formula sits as C13H21ClN2O, showing a balance between lipophilic and hydrophilic parts—this makes it both effective at passing through cell membranes and easy to clear from the body afterward. This balance directly influences both its onset of action (often within minutes) and how long its numbing effect lasts. Simple but crucial details like solubility and melting point guide not only pharmacists but also researchers designing new delivery systems.
Pharmaceutical-grade prilocaine hydrochloride gets produced and tested to strict standards, usually reaching over 99% purity. Impurities, such as related substances or heavy metals, have to hit extremely low thresholds set by national pharmacopeias. Labels do more than just list a name or company—they provide concentration, batch number, date of manufacture, storage instructions, and warnings about dosage or side effects. In my experience, well-labeled drugs mean fewer administration errors and less trouble for frontline health workers. Proper labeling not only prevents potential mishaps under pressure but also helps clinics trace any issues to their sources, fostering safer and more reliable patient care.
Synthesizing prilocaine hydrochloride starts with reacting o-toluidine and 2-bromopropionyl bromide to get the amide structure ready, followed by treating this intermediate with isopropylamine. The final hydrochloride salt forms by neutralizing with hydrochloric acid. Labs focus on using clean, controlled conditions to keep by-products and unwanted chemical residuals as low as possible. Years ago, I saw the difference that precise synthesis made—impure batches risk both patient safety and market recall, which financially and ethically hits everyone involved. Even small-scale errors can result in significant toxicity issues or allergic responses that no one can afford to overlook.
Prilocaine’s structure offers chemists several chances for modification. Small changes on the aromatic ring or amide side chain can affect how quickly the drug works and how long it lasts in the body. These modifications help companies carve out specialized uses—like targeting pain relief for patients with rare enzyme deficiencies or creating formulations with unique absorption profiles. Research into new derivatives, including those where prilocaine hooks up with other molecules to fight infection, shows a future defined by multi-purpose anesthetics. Each tweak brings challenges for safety and stability, so these modifications require rigorous checking at every step.
Anyone scanning pharmacy shelves or medical records might spot prilocaine listed under several names. Its International Nonproprietary Name is just ‘prilocaine’, but folks might encounter terms like Citanest, or combine it with lidocaine in the well-known EMLA cream. While these synonyms might seem trivial, keeping track of them prevents medication errors that can result from mix-ups in busy clinics or operating rooms. In cross-border research, having the right name can speed up literature searches or avoid confusion in patient care. Clear communication, especially across countries, matters more than ever as medical teams grow increasingly international.
Using prilocaine hydrochloride safely doesn’t just depend on the molecule itself—it involves the procedures and safety cultures built around it. Medical teams must be aware of the risks for methemoglobinemia, a potentially life-threatening condition if the drug gets used in high doses or in patients with particular enzyme defects. On the operational front, institutions need rigorous protocols for dosing and monitoring, especially in children or folks with known risk factors. I’ve watched the best results come from environments where regular training, clear documentation, and ongoing vigilance combine with up-to-date equipment. Standards can’t just sit on paper; they deserve active commitment.
Prilocaine hydrochloride goes beyond the dentist’s chair. Besides dental work, this anesthetic finds regular use in minor surgical procedures, obstetric anesthesia, and as a component of topical creams used to numb skin before needle insertions or minor surgery. Its ability to provide pain relief with little cardiac or central nervous system disturbance suits both outpatient and inpatient procedures. Emergency services, wound clinics, and pain management centers keep it on hand because prilocaine can handle rapid, reliable local anesthesia without requiring sedation or risking severe drug interactions. This kind of flexibility distinguishes it from older or more specialized agents, and steers countless patients toward quicker, safer recoveries.
Research around prilocaine hydrochloride now stretches from tweaking its chemical structure to exploring fresh administration routes. Scientists seek shorter onset times, longer-lasting pain relief, and minimal risk of systemic toxicity. Others dig into the search for tailored formulations that serve patients with pre-existing medical conditions, which sometimes block the use of standard anesthetics. Recent years brought promising nanoparticle delivery options, or combinations with other medications to speed up wound healing or fight infection. R&D teams in both public and private labs keep pushing—sometimes spurred by patient stories or emerging market needs. Their work shapes new guidelines, raises the safety bar, and hopefully helps contain healthcare costs by reducing complications.
The body usually clears prilocaine pretty well, but big doses or certain genetic backgrounds increase the risk for methemoglobinemia, where hemoglobin can’t carry oxygen the way it should. Researchers log every reaction, tracking symptoms and outcomes to build better risk profiles. Meticulous toxicity work matters, because sometimes what seems a safe drug can surprise with a rare but serious event. Care teams learn from each other’s experiences, revising protocols to identify susceptible patients faster and mitigate harm. Continuing investment in animal and clinical studies sharpens understanding—not just of acute risks, but of how low-level, repeated exposure affects the body over the years, especially in children or sensitive groups.
Looking ahead, prilocaine hydrochloride stands to play a bigger role both on its own and combined with other therapies. Personalized medicine beckons, with genetic testing helping predict who might have an adverse reaction and who enjoys the best pain relief. Smarter delivery methods, maybe via patches, sprays, or even biodegradable implants, aim to raise both safety and convenience for patients and providers alike. Environmental impact, from manufacturing waste to disposal, also nudges the industry to rethink process chemistry, seeking greener, less hazardous synthesis. As healthcare demands climb and resources stretch thin, reliable, affordable local anesthetics like prilocaine keep building their case—not just for regular use, but as launchpads for the next generation of safer, more effective pain management solutions.
People often don’t think twice before a dentist picks up a syringe or a surgeon prepares a patient for a minor procedure. Behind that confidence sits the assurance that numbing agents like prilocaine hydrochloride work efficiently to take away pain. In practice, I've met countless patients who worry less not because they don't hurt, but because the right local anesthetic turns a terrifying experience into a manageable one. Prilocaine hydrochloride isn’t just another option—it's essential for a smooth, less stressful visit to the dentist or operating room.
Prilocaine hydrochloride belongs to a group of local anesthetics known as amides. It usually comes in injection form and steps in to numb a chosen area of tissue just long enough so procedures can be done without discomfort. Dentists and doctors reach for prilocaine because it doesn’t linger longer than necessary and rarely leads to strong allergic reactions compared to older options like procaine. For years, dental clinics have blended prilocaine with other agents, such as lidocaine, to balance effectiveness and safety.
Local anesthetics aren’t just about “shutting off pain.” They call for a careful touch, especially in those with certain blood disorders or liver issues. Prilocaine can cause methemoglobinemia, a rare condition that affects how blood carries oxygen—I've watched experienced clinicians stay alert for signs, adjusting doses carefully. Knowing these risks, maintaining open communication with patients, and updating medical histories always plays a key part in safe care.
Prilocaine hydrochloride reaches beyond dental chairs and into hospitals for things like stitching wounds or preparing before small skin surgeries. The topical mix of prilocaine with lidocaine under the brand name EMLA makes blood draws and minor skin procedures easier for children and adults who hate needles. For those with a needle phobia or a low pain threshold, this anesthetic drops anxiety levels, making medical care more accessible.
In the healthcare system, medications only help if people receive the correct dose from professionals who know both benefits and the risks. With prilocaine hydrochloride, experience counts. The best care springs from providers who weigh each patient’s health, allergies, and potential interactions with other medicines. Healthcare teams that put safety first avoid missteps and catch rare side effects early, protecting their patients.
Problems sometimes show up in less-resourced clinics or places where staff rotate quickly. In these settings, incomplete medical histories spark trouble. Solutions aren’t high-tech: regular training for staff, clear protocols, and easy access to information save lives and prevent complications. Better reporting systems help track side effects and sharpen the care that follows.
I’ve seen patients walk into clinics with pain etched on their faces and walk out relieved, thanks to drugs like prilocaine hydrochloride. Whether helping a child tolerate a blood draw or supporting a patient through dental surgery, these small moments build trust. Every time I see relief after worry in a patient’s eyes, it reinforces the belief—tools like this anesthetic aren’t extras. They are building blocks of compassionate, expert healthcare.
Plenty of people know the sting of a needle at the dentist’s office or the anxiety that creeps in before minor surgery. Prilocaine hydrochloride, a local anesthetic, steps in to numb pain, making procedures easier to bear. I remember sitting as a child, seeing the dentist draw a small needle before filling a tooth, and wondering if the numbness would last forever. Back then, I never considered what can go wrong if that magic numbing agent sets off side effects.
Part of my job as a writer involves talking to healthcare workers, listening to stories about patients feeling faint or lightheaded after an injection of prilocaine. The most frequent complaints sound pretty similar: some swelling around the site, skin turning pale, or tingling that spreads beyond the original spot. All these sensations usually pass in an hour or so, but anyone who leaves the dental chair shivering or sweating knows it's tough to brush off.
Not every medicine throws out rare complications, but prilocaine carries one. It can nudge the blood away from its usual work—carrying oxygen. That change, called methemoglobinemia, makes skin turn dark or bluish and brings shortness of breath. This is not a regular occurrence. According to data out of several university medical centers, the risk rises with large doses, or in babies and certain people with underlying red blood cell issues. Doctors can reverse this if caught early, but only if folks recognize the warning signs.
Fingers start turning blue, lips lose their color, headaches last longer than expected, or thinking feels foggy. These signals don’t always show up together, though even a single symptom asks for a quick call to the doctor. I once heard a nurse tell her trainee: “Anyone breathing heavy after numbing, ask questions. Don’t wait.” Simple advice, but it saves lives.
Prilocaine can sometimes make hearts race or pound, especially if someone’s already nervous. While rare, a drop in blood pressure or a feeling that the floor is tilting can set in. Allergic reactions bring their own set of troubles; hives might show up, faces could swell, and trouble swallowing might follow. Anyone with these reactions needs quick attention.
Medical teams share plenty of tips. They check health histories before numbing, ask about genetic conditions, and measure dosages for children with extra care. Most side effects come from getting too much too fast. Clinics double-check syringes and watch for drug interactions. I’ve met pharmacists who stay on the phone with anxious parents after a child’s treatment, listening for telltale symptoms and keeping tired hands steady.
No medication stands alone. The World Health Organization and the U.S. Food and Drug Administration publish clear warnings about prilocaine’s side effects. Every healthcare provider works with this data, updating protocols as research evolves. Sharing honest stories, relying on strong science, and asking questions at the doctor’s office do more than relieve pain—they protect people from the shadow side of help.
In dental clinics and hospitals, Prilocaine Hydrochloride shows up under the sharp end of a syringe. Nobody wakes up hoping for a shot in the mouth or arm, but that’s how this local anesthetic does its job. Dentists rely on it every week, mostly for numbing a section before digging into a tooth. Nurses use it for minor skin surgeries, and even tattoo artists sometimes work with medical professionals to ease the sting for anxious clients. Getting an injection isn’t anyone’s highlight, but if someone offered a filling without any anesthesia, most of us would sprint the other way.
Doctors favor Prilocaine Hydrochloride over similar drugs for a few strong reasons. For patients with sensitivities to other anesthetics or folks at risk of heart issues, it brings less of the jitters. A 2023 review in The Journal of Clinical Anesthesia pointed out that its risk of allergic reactions or toxic side effects runs lower than lidocaine in many cases. As someone with a heart condition once told me, knowing the local numbing agent is a bit gentler on the body puts the mind at ease. In my own family, relatives with cardiac issues had surgeries where the anesthesiologist made this specific choice instead of something else, hoping for a smoother ride through the procedure.
The way this drug enters the body mostly depends on what hurts and where. Dentists inject it into the gum, targeting nerves that won’t let pain signals get back to the brain. Deeper injections, like spinal or epidural blocks, take care of numbness for bigger procedures, such as operations on the lower body. In hospitals, doctors sometimes rub a topical version onto the skin for minor skin treatments or to ready the site for a larger needle. I remember a time when a pediatric nurse dabbed a bit of a prilocaine mix on my nephew’s skin before giving him stitches. He hated the bright lights and sterile trays, but at least he didn’t twitch with every poke.
No medication slides by without some risk. Too quick a dose, or too much at once, can trigger methemoglobinemia—a word few can pronounce but no one wants to experience. This condition affects how blood carries oxygen. According to the FDA, infants especially face danger if given high doses. Adults can run into trouble, too, if doctors miss underlying enzyme deficiencies. I’ve seen the worried faces of parents as they double-checked dosages after reading about this risk online. Honest conversations matter between patient and provider. Full disclosure about allergies, ongoing illnesses, and even what’s in the medicine cabinet at home help keep these rare complications even rarer.
Asking questions helps put patients back in the driver’s seat. Clinics can keep real-time feedback forms and train staff to explain what’s happening at every step. For anxious patients, doctors could let people know how quickly numbing will kick in, how long it tends to last, and what to watch for afterward. A small heads-up goes a long way based on my own time in waiting rooms, overhearing people whispering worries to one another.
New research keeps pushing this field forward. Experts published a 2022 analysis reviewing new delivery devices designed to measure the correct dose each time, hoping to stop mistakes before they start. If clinics combine these technologies with solid patient education and thoughtful monitoring, chances for safe and comfortable care get stronger for everyone who crosses their threshold.
Prilocaine Hydrochloride serves as a local anesthetic, commonly used in dental procedures and minor surgeries to block nerve signals and numb specific areas. Like any medicine, it works wonders when used for the right person but carries real risks for others. Doctors always ask questions before using numbing shots for a reason. Understanding who should steer clear of Prilocaine Hydrochloride means safer patient care and fewer complications.
People with certain blood disorders face higher risks. One condition, methemoglobinemia, stands out. Prilocaine Hydrochloride can cause this rare but dangerous problem, turning part of the blood’s hemoglobin into a form that can’t carry oxygen well. For folks born with enzyme issues (like glucose-6-phosphate dehydrogenase deficiency or NADH-methemoglobin reductase deficiency), this risk climbs even more. Cyanosis, which makes lips and skin look blue from poor oxygen delivery, comes sharply into play. These aren’t distant textbook warnings; hospital stays prove this risk pops up quickly after Prilocaine in sensitive patients.
Babies under six months have higher vulnerability. Their developing bodies can’t handle changes in blood chemistry like older children or adults can. Cases of methemoglobinemia and low oxygen levels have occurred in infants given Prilocaine. Sick or premature babies prove especially at risk. The FDA, professional groups, and multiple pediatricians avoid using this anesthetic in such cases. Simple solutions involve switching to safer options for infants who need pain control.
Prilocaine crosses the placenta and enters breast milk. Research into the effects during pregnancy stays limited, but possible links to fetal harm or blood changes can’t be dismissed. Nursing mothers also run the risk of passing small doses to babies through milk. Physicians usually weigh benefits against these risks and turn to other medications with a stronger safety record in expectant or lactating women.
Heart and lung patients depend on healthy oxygen levels more than most. Because Prilocaine can lower those levels in rare cases, anyone with angina, heart failure, severe COPD, or related problems could react badly. Since the liver clears this drug, those with liver disease might struggle to break it down efficiently, raising toxicity risks. History shows that people in these categories have fared better with other anesthetics, especially if medical staff knows the patient’s full list of conditions.
Anyone who has reacted badly to Prilocaine or similar anesthetics (like lidocaine or articaine) shouldn’t get it again. Allergic reactions range from mild rash to full-blown anaphylaxis, which medical responders see every year. If there’s history of allergy, other numbing agents with unrelated structures usually work without trouble.
Honest conversations between doctors and patients fix most safety gaps. Asking about health history, allergies, medications, and family problems with anesthesia takes just minutes. Blood tests for those with questionable histories help catch hidden risks. I’ve seen dentists flag high-risk children and choose alternative options with no drama. Patient safety gets a real boost with this kind of upfront effort, and well-supported choices help clinics avoid unexpected medical emergencies. Making time for careful screening feels like common sense, but it still saves lives and builds deeper trust.
Prilocaine Hydrochloride often serves as a local anesthetic, doing its job during dental procedures, minor surgery, or even tattoo sessions. People count on it to block pain, but safety isn’t automatic just because it’s widely used. For someone handling this drug or receiving it, some real precautions always matter.
Anyone with a history of blood disorders, like methemoglobinemia, faces higher risk with prilocaine. This isn’t just a paper warning—prilocaine can actually shift hemoglobin, making it harder for your blood to carry oxygen. For newborns, small children, and adults with certain enzyme deficiencies, the stakes climb. I once saw an otherwise healthy adult get unexpectedly blue lips after dental anesthesia; the culprit turned out to be unnoticed methemoglobinemia triggered by prilocaine. That moment stuck with me, driving home the reality.
Doctors and nurses get clear guidelines: use the lowest possible dose for the shortest time needed. Prilocaine absorbs fast—especially in large or inflamed areas. Even folks with no medical background should know that bigger doses don’t equal longer relief; instead, they boost the odds of side effects like dizziness, drowsiness, or twitching. For this reason, practitioners check weight and health status every time before deciding how much to inject or apply.
Signs of trouble can start with skin rash or swelling but sometimes slip in quieter, like sudden confusion or fast heartbeats. Most people shrug off an odd tingle or pale lips, thinking it’s nerves, but with prilocaine, those are warning signals. It helps to watch closely for symptoms for a couple of hours after use and contact medical help fast if something feels off.
Some medications just don’t play well with prilocaine. Acetaminophen, some sulfa drugs, and nitrites can boost the risk of methemoglobinemia. Even over-the-counter cold remedies might quietly mess with how prilocaine works in the body. Every doctor’s visit or pharmacy trip should involve mentioning recent prilocaine use. That little habit keeps drug interactions in check.
Pregnant or breastfeeding people, and those with liver or kidney concerns, stand to face extra risks. Prilocaine can travel beyond its target area. Mothers should talk openly with their doctors before treatment. This brings the chance to weigh alternatives or pick safer dosages.
Clinicians using prilocaine move with more confidence after good training. They recognize early warning signs of methemoglobinemia, know where to find antidotes like methylene blue, and have practiced their emergency steps. Even so, professionals keep up-to-date with the latest safety updates and dosing charts. Not all staff in clinics get this message, especially outside hospital walls.
Some folks think local anesthetics are harmless since they aren’t swallowed or injected into big veins. Experience proves otherwise. Respecting the power of drugs like prilocaine and never treating them as routine can prevent risks before they start. That means talking openly with healthcare providers, asking questions, and understanding personal health history—simple habits that can sidestep big problems down the road.
| Names | |
| Preferred IUPAC name | 2-(propylamino)-N-(2-methylphenyl)propanamide hydrochloride |
| Other names |
Citanest Propitocaine hydrochloride Prilocaine HCl |
| Pronunciation | /ˈpraɪ.ləˌkeɪn haɪˌdrɒk.ləˌraɪd/ |
| Identifiers | |
| CAS Number | 1786-81-8 |
| Beilstein Reference | 3620746 |
| ChEBI | CHEBI:8497 |
| ChEMBL | CHEMBL1200458 |
| ChemSpider | 16289 |
| DrugBank | DB00750 |
| ECHA InfoCard | 36c229ed-8d59-4c5f-88e0-ceecfbceb8e1 |
| EC Number | EC 200-293-7 |
| Gmelin Reference | 79048 |
| KEGG | D08374 |
| MeSH | D017060 |
| PubChem CID | 71470 |
| RTECS number | UC6409000 |
| UNII | 9A206043KT |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | DTXSID7020637 |
| Properties | |
| Chemical formula | C13H21ClN2O |
| Molar mass | 271.8 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.1 g/cm3 |
| Solubility in water | Very soluble in water |
| log P | -2.2 |
| Acidity (pKa) | 7.89 |
| Basicity (pKb) | 7.89 |
| Magnetic susceptibility (χ) | -64.5e-6 cm³/mol |
| Refractive index (nD) | 1.510 |
| Viscosity | Viscosity: 6.28 mPa·s (20°C, 25% solution) |
| Dipole moment | 4.77 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 369.4 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -285.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | Std enthalpy of combustion (ΔcH⦵298) of Prilocaine Hydrochloride: -5968 kJ/mol |
| Pharmacology | |
| ATC code | N01BB04 |
| Hazards | |
| Main hazards | May cause methaemoglobinaemia. |
| GHS labelling | GHS labelling: "Danger; H301, H311, H317, H319, H373, P260, P280, P301+P310, P302+P352, P305+P351+P338, P310 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H312: Harmful in contact with skin. H332: Harmful if inhaled. |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| Flash point | > 188.5°C |
| Autoignition temperature | 195°C |
| Lethal dose or concentration | LD50 oral rat 425 mg/kg |
| LD50 (median dose) | LD50 (median dose): 640 mg/kg (intravenous, mouse) |
| NIOSH | PD0450000 |
| PEL (Permissible) | 50 ppm |
| REL (Recommended) | 300 mg daily |
| IDLH (Immediate danger) | 85 mg/m³ |
| Related compounds | |
| Related compounds |
Prilocaine Lidocaine Bupivacaine Mepivacaine Articaine Ropivacaine Etidocaine |
